Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

InSite Vision and Bausch & Lomb announce alliance regarding glaucoma drug

July 26, 1996

Pharmos receives grant to develop loteprednol/tobramycin combination product

July 19, 1996

FDA will review BioLon PMA

July 5, 1996

Allergan's Acular available on U.K. market

June 14, 1996

Xalatan approved for U.S. market

June 14, 1996

InSite Vision and Ciba Vision marketing agreement for sustained-release eyedrop formulation

June 7, 1996

Ofloxacin ophthalmic solution receives FDA approval

May 31, 1996

Carbonic anhydrase inhibitors from Alcon

May 31, 1996

Anti-VEGF oligonucleotides inhibit retinal neovascularization in preclinical model

May 17, 1996

SnET2 enters phase I/II for AMD indication

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...